B of A Securities Downgrades CME Gr to Underperform, Lowers Price Target to $177
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has downgraded CME Group from Neutral to Underperform, reducing the price target from $212 to $177.
September 03, 2024 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities has downgraded CME Group from Neutral to Underperform, with a new price target of $177, down from $212.
The downgrade from Neutral to Underperform by a major analyst like B of A Securities is likely to negatively impact investor sentiment and could lead to a short-term decline in CME's stock price. The significant reduction in the price target from $212 to $177 further supports a bearish outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100